Back to Search
KYLE HOLEN, MD
MD
Medical Oncology Physician
NPI: 1316908783Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
44611(WI)
Research & Publications (20)
The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor.
PMID 17924057·Invest New Drugs·2008
3-trial
Therapeutic and palliative options for diffuse neuroendocrine metastatic disease.
PMID 16622986·J Gastrointest Surg·2006
6-review
Target practice: figuring out which, when, and why to use systemic therapies for metastatic colon cancer.
PMID 16466998·Cancer Invest·2006
6-review
Amongst eligible patients, age and comorbidity do not predict for dose-limiting toxicity from phase I chemotherapy.
PMID 19649630·Cancer Chemother Pharmacol·2010
8-other
Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies.
PMID 19228747·Clin Cancer Res·2009
3-trial
A phase I study of an oral simulated FOLFOX with high dose capecitabine.
PMID 19129971·Invest New Drugs·2009
3-trial
Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.
PMID 19274042·Clin Adv Hematol Oncol·2009
6-review
Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.
PMID 18841362·Cancer Chemother Pharmacol·2009
3-trial
More on reports of esophageal cancer with oral bisphosphonate use.
PMID 19391256·N Engl J Med·2009
8-other
Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.
PMID 18941749·Cancer Chemother Pharmacol·2009
4-observational
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.
PMID 18278438·Invest New Drugs·2008
3-trial
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative study.
PMID 19047123·Clin Cancer Res·2008
3-trial
Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma.
PMID 18322441·Clin Adv Hematol Oncol·2008
3-trial
ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line.
PMID 18299943·J Gastrointest Surg·2008
8-other
Guillain-Barré syndrome after treatment with sunitinib malate?
PMID 18251284·Oncology (Williston Park)·2008
6-review
A phase I trial of CEP-701 + gemcitabine in patients with advanced adenocarcinoma of the pancreas.
PMID 18217204·Invest New Drugs·2008
3-trial
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors.
PMID 18172649·Cancer Chemother Pharmacol·2008
3-trial
Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.
PMID 18061679·J Inorg Biochem·2008
8-other
Treatment with panitumumab after a severe infusion reaction to cetuximab in a patient with metastatic colorectal cancer: a case report.
PMID 17553202·Clin Colorectal Cancer·2007
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 265-1700
Quick Facts
- NPI
- 1316908783
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile